Essential Medicines Strategic Stockpile Act of 2020

Summary

Essential Medicines Strategic Stockpile Act of 2020 This bill requires the Department of Health and Human Services (HHS) to create a pilot program with private entities to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage. Specifically, HHS must enter into contracts of up to three years for entities to create a six-month stockpile of up to 50 types of such drugs. The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 1 October 2020

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

2. 1 October 2020

   Introduced

   Introduced in House

   Source: IntroReferral

3. 1 October 2020

   Introduced

   Introduced in House

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in House · 1 October 2020 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 1 October 2020

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 1 October 2020

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 1 October 2020

  Open at official source

Sponsors

• Rep. Carter, Earl L. "Buddy" [R-GA-1] · R · Sponsor
• Sen. Blunt Rochester, Lisa [D-DE] · D · Sponsor
• · hsif00 · Standing

Related records

• related to → Commitment to Defeat the Virus and Keep America Healthy Act